Current Psoriasis News and Events | Page 14

Current Psoriasis News and Events, Psoriasis News Articles.
Sort By: Most Relevant | Most Viewed
Page 14 of 14 | 534 Results
Integrins and signaling in psoriasis
The development of keratinocytes in the skin provides one of the clearest examples of a regulated change in cellular adhesion. Basal stem cells and their immediate progeny, the pluripotent (2001-08-15)

Rush seeking patients with psoriatic arthritis for drug trial
Patients with psoriatic arthritis are being sought to participate in a drug trial at Rush-Presbyterian-St. Luke's Medical Center in Chicago. Psoriatic arthritis is an inflammatory type of arthritis that occurs in approximately 10 percent of the patients with psoriasis. (2000-04-05)

Wake Forest study shows women suffer from 'gender gap' in treatment of severe psoriasis
When it comes to the treatment of severe psoriasis, there is no equality between the sexes. Men have enjoyed the benefit of powerful drugs that address the disease, but women of childbearing age have gone without, according to dermatologists at the Westwood Squibb Center for Dermatology Research at Wake Forest University School of Medicine. (2000-04-02)

New quit strategy offers smokers more pleasure, less risk
By targeting the enzyme that metabolizes nicotine, researchers at the University of Toronto have devised a new strategy to wean smokers from cigarettes. (2000-03-14)

Results of ENBREL(R) in phase II clinical trial in patients with psoriasis and psoriatic arthritis to be featured at AAAAI late-breaker session
Results of a Phase II clinical trial of ENBREL in patients with psoriasis and psoriatic arthritis will be featured at the Late-Breaker Abstract Session at the American Academy of Allergy, Asthma and Immunology's (AAAAI) 56th Annual Meeting (2000-03-01)

Abgenix reports positive clinical data with ABX-IL8 in Psoriasis
Abgenix, Inc. (Nasdaq: ABGX) reported results of its Phase I/II clinical trial with ABX-IL8, a fully human antibody therapy for psoriasis developed with the company's XenoMouseâ„¢ technology. ABX-IL8 was safe and well tolerated at all dose levels tested and that a dose-dependent improvement was seen in multiple measures of disease. (1999-11-30)

Patients with severe psoriasis suffer daily, study finds
Psoriasis significantly reduces quality of life, according to researchers at Wake Forest University Baptist Medical Center. (1999-09-02)

Sensible health warnings to stay out of sun may also be denying some people the benefits it provides
Are the effects of the sun bad for all people? In this week's BMJ, researchers say that the public should be educated on both the pros and cons of sunlight exposure, so that they can weigh up the associated risks for themselves. (1999-07-09)

Research Findings Suggest Potent, Broad-Spectrum Antiviral Activity For Vertex's Investigational IMPDH Inhibitor VX-497
The investigational drug VX-497 may have potent, broad- spectrum antiviral activity, according to laboratory results from Vertex Pharmaceuticals being presented at ICAR. VX-497's activity against viruses in cell culture was compared to ribavirin, both alone and in combination with interferon-alpha. VX-497 Phase II clinical trials are underway for HCV and psoriasis. (1999-03-25)

Blocking Autoimmunity Naturally
Weizmann Institute scientists have discovered a mechanism that may lead to the development of a selective treatment for autoimmune disorders. (1999-03-15)

Growth Factor Contributes To Angiogenesis
A University of Michigan team has found that a natural substance known as vascular endothelial growth factor (VEGF) contributes to angiogenesis not only by stimulating blood vessel growth, but also by prolonging the survival of blood vessel cells. (1999-02-02)

Meditation Speeds Treatment Of Psoriasis
Psoriasis patients who practiced meditation-based relaxation while undergoing ultraviolet (UV) light treatments experienced quicker clearing of their skin lesions than did patients who received UV treatments alone, according to results of a small randomized controlled trial by Dr. John Kabat-Zinn and colleagues at the University of Massachusetts Medical School. (1998-09-23)

Angiogenesis Research May Lead To Treatments
Research on this process not only may lead to improved cancer treatments, but also may offer new approaches to treating a wide range of other medical problems, says Peter Polverini, U-M professor of dentistry and pathology who has been doing research on angiogenesis for 20 years. (1998-05-20)

Three-Dimensional Structure Of Human Lung Tryptase Determined, An Enzyme Involved In Allergic Asthma
Scientists at the Max Planck Institute of Biochemistry, Martinsried/Germany, working in collaboration with their colleagues at the University of Muenchen have recently unravelled the three-dimensional structure of beta-tryptase, a mast cell-specific serine proteinase that may be involved in causing asthma and other allergic and inflammatory disorders (nature, 392, 306-310). (1998-03-25)

Page 14 of 14 | 534 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to